TrianglePUBLICATIONS · 20697069
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2010 Oct 10
- First author
- Lin TS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Lin TS
- type
- Author
- name
- Donohue KA
- type
- Author
- name
- Byrd JC
- type
- Author
- name
- Lucas MS
- type
- Author
- name
- Hoke EE
- type
- Author
- name
- Bengtson EM
- type
- Author
- name
- Rai KR
- type
- Author
- name
- Atkins JN
- type
- Author
- name
- Link BK
- type
- Author
- name
- Larson RA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Lin TS
- type
- Author
- name
- Donohue KA
- type
- Author
- name
- Byrd JC
- type
- Author
- name
- Lucas MS
- type
- Author
- name
- Hoke EE
- type
- Author
- name
- Bengtson EM
- type
- Author
- name
- Rai KR
- type
- Author
- name
- Atkins JN
- type
- Author
- name
- Link BK
- type
- Author
- name
- Larson RA
- type
- Author
- bibliography ids
- nci-bib-ca6cc9688a32ce06f40a9040
- book metadata
- content sha256
- a44b86b093d97b5f12771ee8296d9e85853c13bed467ed45f2ef837066836557
- document type
- citation
- dois
- 10.1200/JCO.2010.29.7978
- electronic publication date
- display
- 2010 Aug 9
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20697069
- immutable id
- pubmed:20697069@a44b86b093d97b5f12771ee8296d9e85853c13bed467ed45f2ef837066836557
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 29
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4500-6
- volume
- 28
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 20697069
- provenance
- batch id
- 10a38257e12e9ed1867a
- provider
- NCBI PubMed ESummary
- record sha256
- 6d3173710983272a67232277da5d4ec7e7c315b99daac5ba5855ad497dd8ba17
- response sha256
- 84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
- retrieved at
- 2026-09-09T23:46:35.793530+00:00
- publication date
- display
- 2010 Oct 10
- precision
- day
- year
- 2010
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
Preserved source evidence · Not medical advice